Countering deleterious phase transitions in ALS/FTD, PD, AD, and related disorders @Penn @PennMedicine @bb_upenn @BMBGGUPENN @PGGUPenn @PennNGG @CAMBUpenn

University of Pennsylvania
Based in United States
Filter
Exclude
Time range
-
Minimum likes
The ALS community has lost one of its most powerful voices. Brooke Eby was diagnosed with ALS in 2022 at just 33 years old. Instead of retreating, she made a choice that changed how the world sees this disease: she shared it all, with honesty and a sense of humor that made it impossible to look away. She brought her employer Salesforce into the fight and raised more than $1 million for research. She helped build ALStogether so people with ALS could find one another. And she shared her story with the Today Show, The New York Times and People. In 2024, the ALS Association was proud to name her an ALS Hero. "Brooke made ALS impossible to ignore, and she made it impossible not to love her while she did it," said ALS Association President and CEO Calaneet Balas. Brooke died Thursday at 37. We will keep going until ALS is livable for everyone, and then cured. Read our full statement: als.org/stories-news/brooke-…
58
210
1,666
61,235
From Human to Mouse, Tau Strains Stay True to Structure alzforum.org/news/research-n…
1
2
917
In @elife: HAX1 drives assembly and activation of the mitochondrial intermembrane space chaperone CLPB doi.org/10.7554/eLife.112857…
1
1
4
1,049
In @elife: Thermodynamic principles of enzymatic regulation in biomolecular condensates from reaction-coupled molecular modeling doi.org/10.7554/eLife.112417…
1
1
6
896
Self-assembling polymers work up some nerve Micrometer-long peptide amphiphile fibrils enhance neuronal adhesion and function: science.org/doi/10.1126/scie…
2
26
2,265